Top Tweets for #hid25
🎤 “Hypercortisolism’s effect on the kidney, which is very important, causes kidney dysfunction.”
@nephonline associate editor Lance Sloan, MD, speaks about how cortisol affects kidney health 👇
#HiD25 @HeartinDiabetes @YHandelsmanMD @CardiologyToday
https://t.co/JN3OdWW3Wz
Ayodele Odutayo, MD, DPhil, was presented with the Rising Star Award in Diabetes Cardiorenal & Metabolic Medicine at @HeartinDiabetes #HID25 @YHandelsmanMD @endocrinetoday @nephronline
https://t.co/W0dpPSb5lx
With only 1 medication historically used to treat diabetic kidney disease, study of combination therapies with newer medicines is warranted + may improve outcomes in this population @HeartinDiabetes #HID25 @YHandelsmanMD @endocrinetoday @nephronline
https://t.co/W0dpPSb5lx
📣 “I think there’s going to be some new interest in ways to manage hypertension.” – @RPratleyMD at #HiD25
Hear more key takeaways from Dr. Pratley in our exclusive video interview at @HeartinDiabetes 👇
@YHandelsmanMD @CardiologyToday
https://t.co/FJtysYNO3k
At #HID25, speakers highlighted four recent reports published in @ACCinTouch focusing on health technology, diet, diabetic cardiomyopathy and lifestyle @HeartinDiabetes @YHandelsmanMD @EndocrineToday @GoHealio
https://t.co/myiLCNc9Gx
During #HiD25, we met with Timothy Garvey, MD, to discuss the Lancet Commission on Obesity, which broke new ground by differentiating between preclinical and clinical obesity.
Watch the full interview: https://t.co/Zxqigcn0gr
New at #HiD25: Kausik Ray FMedSci, director of the Imperial Centre for Cardiovascular Disease Prevention, sat down with us to discuss his presentation on CETP inhibitors and how they may be used to predict cardiovascular events.
Watch the full interview: https://t.co/AS0uYMHqXX
☕ Catch up on some of the biggest storylines from #HiD25!
Healio spoke with Richard Pratley, MD, about his biggest takeaways from last weekend’s meeting.
@HeartinDiabetes @YHandelsmanMD @CardiologyToday
https://t.co/FJtysYNO3k
New at #HiD25: We sat down with Matthew Budoff, MD, to discuss his recent study on predicting cardiovascular disease in patients without traditional warning signs via serum lipoproteins.
Watch the full interview: https://t.co/KoDNRSwusk
New at #HiD25: Kausik Ray FMedSci, director of the Imperial Centre for Cardiovascular Disease Prevention, sat down with us to discuss his presentation on the future of dual agonists in treating obesity and its many complications.
Watch the full interview: https://t.co/uPn5adI9qq
📹Miss out on some of the lectures at #HID25 or wondering about what you should watch on demand?
Richard Pratley, MD, discusses some of his favorite lectures from this year’s meeting ⬇️
@HeartinDiabetes @YHandelsmanMD @CardiologyToday
https://t.co/FJtysYNO3k
“We really need to be thinking about lipid management very early on, because there are a lot of conditions that are unique to women," Pam R. Taub, MD, of @UCSDHealth, said during @HeartinDiabetes #HID25 @YHandelsmanMD @EndocrineToday @HealioWomen
https://t.co/OWyV0Y4ams
Lipid management for woman requires personalized care that considers sex-specific conditions across the reproductive lifespan, particularly during pregnancy, @PamTaubMD, said during @HeartinDiabetes #HID25 @YHandelsmanMD @EndocrineToday @HealioWomen
https://t.co/OWyV0Y4ams
📹 George Grunberger, MD, speaks with @GoHealio at #HID25 about technology that is currently in the pipeline and may transform how #diabetes comorbidities are managed in the future.
Check out the full video: https://t.co/TuqG98D1FT
@HeartinDiabetes @YHandelsmanMD
💪#GLP1 drugs may provide CV benefit for older adults, but they could also induce lean mass loss that may raise risk for falls.
Health care professionals must individualize #diabetes therapy for all adults, said @RPratleyMD at #HID25.
@HeartinDiabetes
https://t.co/reEne53EJR
SGLT2 inhibitors and GLP-1 RAs have emerged as powerful tools in the management of heart failure.
Hear from @jllbmd @UMJFKcards at @HeartinDiabetes #HID25 about the evolution of how these drugs are viewed in cardiovascular care and their role today:
https://t.co/8G45e84KAj
📱Some types of technology that may improve the management of diabetes-related comorbidities in the future include:
🎯smart contact lenses
🎯cardiac biomarker sensors
🎯neuromodulation devices
@HeartinDiabetes #HID25 @YHandelsmanMD
https://t.co/TuqG98D1FT
During a session at @HeartinDiabetes speakers highlighted four papers recently published in @CircAHA that advance the field of cardiometabolic research #HID25 @YHandelsmanMD @ShahzebKhanMD @mvaduganathan
https://t.co/p86bicE3nq
New from #HiD25: We met with Jennifer Green, MD, Duke University School of Medicine, to discuss her presentation on the future of incretin therapy and how it can be applied to diseases beyond obesity and diabetes.
Watch the full interview: https://t.co/oaN2rV3Bjo
🎤 “We need to personalize therapy in our older adults with #diabetes, even more so than other populations.”
Read more about the talk from @RPratleyMD at #HID25 ⬇️
@HeartinDiabetes @YHandelsmanMD
https://t.co/reEne53EJR
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.7M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.4M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
83.9M followers
Lady Gaga
@ladygaga
75.4M followers
Virat Kohli
@imvkohli
73.3M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.3M followers
Bill Gates
@billgates
65.1M followers
Selena Gomez
@selenagomez
63M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers